Testing effectiveness (Phase 2)Ended earlyNCT05215951What this trial is testingOsimertinib Plus Chemotherapy in Uncommon EGFRm NSCLCWho this might be right forLung Cancer AstraZeneca 4
Not applicableStudy completedNCT07239102What this trial is testingFirmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System MetastasisWho this might be right forEGFR Positive Non-small Cell Lung CancerCentral Nervous System MetastasisLeptomeningeal Metastasis Beijing Tiantan Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01102231What this trial is testingChemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)Who this might be right forStage III Non-small Cell Lung Cancer Intergroupe Francophone de Cancerologie Thoracique 106
Testing effectiveness (Phase 2)Active Not RecruitingNCT05466149What this trial is testingEfficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 InsertionWho this might be right forNSCLC Allist Pharmaceuticals, Inc. 100
Large-scale testing (Phase 3)Study completedNCT00820755What this trial is testingTrial With Cetuximab in Maintenance Therapy After Platinum Based Chemotherapy in First Line Treatment of Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer (NSCLC) Merck KGaA, Darmstadt, Germany 583
Not applicableStudy completedNCT05070026What this trial is testingComparison of Inflammatory Cytokine Levels Between Single-port and Three-port Thoracoscopic Lobectomy in the Treatment of Non-small Cell Lung Cancersurgery on Perioperative Clinical Indexes、Inflammatory Reaction and Quality of Life Scores of Patients With Non-small Cell Lung CancerWho this might be right forVideo-assisted Thoracoscopic SurgeryInflammatory ReactionLife Scores Shengjing Hospital 68
Testing effectiveness (Phase 2)UnknownNCT00801385What this trial is testingSorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyWho this might be right forLung Cancer Yonsei University 47
Testing effectiveness (Phase 2)Ended earlyNCT00526890What this trial is testingCarboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryWho this might be right forLung Cancer Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Ended earlyNCT02831933What this trial is testingTrial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal MelanomaWho this might be right forLung Squamous Cell Carcinoma Stage IVNonsquamous Nonsmall Cell Neoplasm of LungMetastatic Uveal Melanoma Eric Bernicker, MD 11
Testing effectiveness (Phase 2)Looking for participantsNCT06822543What this trial is testingA Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)Who this might be right forLung CancerNon Small Cell Lung CancerBrain Metastases Latin American Cooperative Oncology Group 46
Testing effectiveness (Phase 2)Study completedNCT03322540What this trial is testingPembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)Who this might be right forLung Cancer Incyte Corporation 154
Early research (Phase 1)Study completedNCT04772989What this trial is testingEvaluate AB308 in Combination With AB122 in Participants With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more Arcus Biosciences, Inc. 94
Early research (Phase 1)Study completedNCT03184168What this trial is testingSingle-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male VolunteersWho this might be right forHealthy Volunteers Pfizer 6
Not applicableStudy completedNCT01537991What this trial is testingISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START TrialWho this might be right forLocally Advanced Non-small Cell Lung Cancer Lisette Nixon 81
Not applicableActive Not RecruitingNCT05863052What this trial is testingAnalyzing Clinical Outcomes and Genomic Data of American Indian Patient PopulationWho this might be right forImmune Checkpoint InhibitorsMetastatic Solid TumorNonsmall Cell Lung Cancer+4 more University of Oklahoma 72
Testing effectiveness (Phase 2)WithdrawnNCT02672358What this trial is testingStudy of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLCWho this might be right forNon-Small-Cell Lung Cancer Novartis Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT04913285What this trial is testingEvaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsWho this might be right forSolid Tumor, AdultNon-small Cell Lung CancerMelanoma Pierre Fabre Medicament 400
Testing effectiveness (Phase 2)UnknownNCT00052325What this trial is testingMistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative ChemotherapyWho this might be right forLung Cancer Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableNot Yet RecruitingNCT07310589What this trial is testingEffects of a Visual Interactive LINE Chatbot on Self-Management of EGFR-TKI Related Side Effects in Patients With Lung CancerWho this might be right forNon-Small Cell Lung Cancer National Taiwan University Hospital 178
Early research (Phase 1)Study completedNCT00734890What this trial is testingVandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLung CancerLymphomaLymphoproliferative Disorder+2 more National Institutes of Health Clinical Center (CC) 18